All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-WFY0312 | Anti-EPHA6 (CBFYE-0236) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBFYE-0236 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY0313 | Anti-EPHA6 (CBFYE-0237) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBFYE-0237 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY0314 | Anti-EPHA6 (CBFYE-0991) h(41BB-CD3ζ) CAR, pCDCAR1 | Mouse | CBFYE-0991 | Rat | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY0315 | Anti-EPHA6 (CBFYE-0992) h(41BB-CD3ζ) CAR, pCDCAR1 | Mouse | CBFYE-0992 | Rat | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY0316 | Anti-EPHA6 (CBFYE-0993) h(41BB-CD3ζ) CAR, pCDCAR1 | Mouse | CBFYE-0993 | Rabbit | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY3565 | Anti-EPHA6 (CBFYE-0236) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBFYE-0236 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY3566 | Anti-EPHA6 (CBFYE-0237) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBFYE-0237 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY3567 | Anti-EPHA6 (CBFYE-0991) h(CD28-CD3ζ) CAR, pCDCAR1 | Mouse | CBFYE-0991 | Rat | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY3568 | Anti-EPHA6 (CBFYE-0992) h(CD28-CD3ζ) CAR, pCDCAR1 | Mouse | CBFYE-0992 | Rat | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY3569 | Anti-EPHA6 (CBFYE-0993) h(CD28-CD3ζ) CAR, pCDCAR1 | Mouse | CBFYE-0993 | Rabbit | scFv-CD28-CD3ζ | Lentiviral vector | T cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION